Genetic heterogeneity in familial nocturnal frontal lobe epilepsy

Progress in Brain Research

Volumn 213, Issue C, 2014, Pages 1-15

  Steinlein, Ortrud K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acetylcholine receptor; ADNFLE; DEPDC5; Epileptic encephalopathy; KCNT1; Nocturnal frontal lobe epilepsy

Indexed keywords

ACETYLCHOLINE; CARBAMAZEPINE; DEP DOMAIN CONTAINING PROTEIN 5; NICOTINE; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2; POTASSIUM CHANNEL; POTASSIUM CHANNEL SODIUM ACTIVATED SUBFAMILY T MEMBER 1; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; DISEASE SEVERITY; FAMILIAL DISEASE; FAMILIAL NOCTURNAL FRONTAL LOBE EPILEPSY; FRONTAL LOBE; FRONTAL LOBE EPILEPSY; GENE MAPPING; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; INTELLECTUAL IMPAIRMENT; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPORAL LOBE; GENETICS; MUTATION;

EPILEPSY, FRONTAL LOBE; GENETIC HETEROGENEITY; HUMANS; MUTATION;

EID: 84925386380     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-63326-2.00001-6     Document Type: Chapter

References (53)

1. Aridon P., Marini C., Di Resta C., Brilli E., De Fusco M., Politi F., Parrini E., Manfredi I., Pisano T., Pruna D., Curia G., Cianchetti C., Pasqualetti M., Becchetti A., Guerrini R., Casari G. Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am. J. Hum. Genet. 2006, 79:342-350.
2. Barcia G., Fleming M.R., Deligniere A., Gazula V.R., Brown M.R., Langouet M., Chen H., Kronengold J., Abhyankar A., Cilio R., Nitschke P., Kaminska A., Boddaert N., Casanova J.L., Desguerre I., Munnich A., Dulac O., Kaczmarek L.K., Colleaux L., Nabbout R. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat. Genet. 2012, 44:1255-1259.
3. Bar-Peled L., Chantranupong L., Cherniack A.D., Chen W.W., Ottina K.A., Grabiner B.C., Spear E.D., Carter S.L., Meyerson M., Sabatini D.M. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 2013, 340:1100-1106.
4. Bertrand D., Picard F., Le Hellard S., Weiland S., Favre I., Phillips H., Bertrand S., Berkovic S.F., Malafosse A., Mulley J. How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia 2002, 43:112-122.
5. Bertrand D., Elmslie F., Hughes E., Trounce J., Sander T., Bertrand S., Steinlein O.K. The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits. Neurobiol. Dis. 2005, 20:799-804.
6. Bhattacharjee A., Gan L., Kaczmarek L.K. Localization of the Slack potassium channel in the rat central nervous system. J. Comp. Neurol. 2002, 454:241-254.
7. Biervert C., Schroeder B.C., Kubisch C., Berkovic S.F., Propping P., Jentsch T.J., Steinlein O.K. A potassium channel mutation in neonatal human epilepsy. Science 1998, 279:403-406.
8. Brodtkorb E., Picard F. Tobacco habits modulate autosomal dominant nocturnal frontal lobe epilepsy. Epilepsy Behav. 2006, 9:515-520.
9. Brown M.R., Kronengold J., Gazula V.R., Chen Y., Strumbos J.G., Sigworth F.J., Navaratnam D., Kaczmarek L.K. Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack. Nat. Neurosci. 2010, 13:819-821.
10. Chernova O.B., Somerville R.P., Cowell J.K. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 1998, 17:2873-2881.
11. Cho Y.W., Motamedi G.K., Laufenberg I., Sohn S.I., Lim J.G., Lee H., Yi S.D., Lee J.H., Kim D.K., Reba R., Gaillard W.D., Theodore W.H., Lesser R.P., Steinlein O.K. A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation. Arch. Neurol. 2003, 60:1625-1632.
12. Combi R., Ferini-Strambi L., Tenchini M.L. CHRNA2 mutations are rare in the NFLE population: evaluation of a large cohort of Italian patients. Sleep Med. 2009, 10:139-142.
13. De Fusco M., Becchetti A., Patrignani A., Annesi G., Gambardella A., Quattrone A., Ballabio A., Wanke E., Casari G. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat. Genet. 2000, 26:275-276.
14. Deng P.Y., Rotman Z., Blundon J.A., Cho Y., Cui J., Cavalli V., Zakharenko S.S., Klyachko V.A. FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels. Neuron 2013, 77:696-711.
15. Dibbens L.M., de Vries B., Donatello S., Heron S.E., Hodgson B.L., Chintawar S., Crompton D.E., Hughes J.N., Bellows S.T., Klein K.M., Callenbach P.M., Corbett M.A., Gardner A.E., Kivity S., Iona X., Regan B.M., Weller C.M., Crimmins D., O'Brien T.J., Guerrero-Lopez R., Mulley J.C., Dubeau F., Licchetta L., Bisulli F., Cossette P., Thomas P.Q., Gecz J., Serratosa J., Brouwer O.F., Andermann F., Andermann E., van den Maagdenberg A.M., Pandolfo M., Berkovic S.F., Scheffer I.E. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat. Genet. 2013, 45:546-551.
16. Gu W.L., Brodtkorb E., Steinlein O.K. LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann. Neurol. 2002, 52:364-367.
17. Gu W., Bertrand D., Steinlein O.K. A major role of the nicotinic acetylcholine receptor gene CHRNA2 in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is unlikely. Neurosci. Lett. 2007, 422:74-76.
18. Heron S.E., Smith K.R., Bahlo M., Nobili L., Kahana E., Licchetta L., Oliver K.L., Mazarib A., Afawi Z., Korczyn A., Plazzi G., Petrou S., Berkovic S.F., Scheffer I.E., Dibbens L.M. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 2012, 44:1188-1190.
19. Hirose S., Iwata H., Akiyoshi H., Kobayashi K., Ito M., Wada K., Kaneko S., Mitsudome A. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology 1999, 53:1749-1753.
20. Hoda J.C., Gu W., Friedli M., Phillips H.A., Bertrand S., Antonarakis S.E., Goudie D., Roberts R., Scheffer I.E., Marini C., Patel J., Berkovic S.F., Mulley J.C., Steinlein O.K., Bertrand D. Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore. Mol. Pharmacol. 2008, 74:379-391.
21. Hoda J.C., Wanischeck M., Bertrand D., Steinlein O.K. Pleiotropic functional effects of the first epilepsy-associated mutation in the human CHRNA2 gene. FEBS Lett. 2009, 583(10):1599-1604.
22. Ishida S., Picard F., Rudolf G., Noe E., Achaz G., Thomas P., Genton P., Mundwiller E., Wolff M., Marescaux C., Miles R., Baulac M., Hirsch E., Leguern E., Baulac S. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat. Genet. 2013, 45:552-555.
23. Ishii A., Shioda M., Okumura A., Kidokoro H., Sakauchi M., Shimada S., Shimizu T., Osawa M., Hirose S., Yamamoto T. A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy. Gene 2013, 531:467-471.
24. Ito M., Kobayashi K., Fujii T., Okuno T., Hirose S., Iwata H., Mitsudome A., Kaneko S. Electroclinical picture of autosomal dominant nocturnal frontal lobe epilepsy in a Japanese family. Epilepsia 2000, 41:52-58.
25. Joiner W.J., Tang M.D., Wang L.Y., Dworetzky S.I., Boissard C.G., Gan L., Gribkoff V.K., Kaczmarek L.K. Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits. Nat. Neurosci. 1998, 1:462-469.
26. Kalachikov S., Evgrafov O., Ross B., Winawer M., Barker-Cummings C., Martinelli Boneschi F., Choi C., Morozov P., Das K., Teplitskaya E., Yu A., Cayanis E., Penchaszadeh G., Kottmann A.H., Pedley T.A., Hauser W.A., Ottman R., Gilliam T.C. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat. Genet. 2002, 30:335-341.
27. Kanehira M., Harada Y., Takata R., Shuin T., Miki T., Fujioka T., Nakamura Y., Katagiri T. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis. Oncogene 2007, 26:6448-6455.
28. Klingensmith J., Nusse R., Perrimon N. The Drosophila segment polarity gene dishevelled encodes a novel protein required for response to the wingless signal. Genes Dev. 1994, 8(1):118-130.
29. Koelle M.R., Horvitz H.R. EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell 1996, 84:115-125.
30. Kremer E.J., Pritchard M., Lynch M., Yu S., Holman K., Baker E., Warren S.T., Schlessinger D., Sutherland G.R., Richards R.I. Mapping of DNA instability at the fragile-X to a trinucleotide repeat sequence P(Ccg)N. Science 1991, 252:1711-1714.
31. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
32. Leppert M., Anderson V.E., Quattlebaum T., Stauffer D., O'Connell P., Nakamura Y., Lalouel J.M., White R. Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 1989, 337:647-648.
33. Li C., Bassell G.J., Sasaki Y. Fragile X mental retardation protein is involved in protein synthesis-dependent collapse of growth cones induced by semaphorin-3A. Front. Neural Circuits 2009, 3:11.
34. Magnusson A., Stordal E., Brodtkorb E., Steinlein O. Schizophrenia, psychotic illness and other psychiatric symptoms in families with autosomal dominant nocturnal frontal lobe epilepsy caused by different mutations. Psychiatr. Genet. 2003, 13:91-95.
35. Martin C., Meloche C., Rioux M.F., Nguyen D., Carmant L., Andermann E., Gravel M., Cossette P. A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the French-Canadian population. Clin. Genet. 2013, [ahead of print]. 10.1111/cge.12311.
36. McLellan A., Phillips H.A., Rittey C., Kirkpatrick M., Mulley J.C., Goudie D., Stephenson J.B.P., Tolmie J., Scheffer I.E., Berkovic S.F., Zuberi S.M. Phenotypic comparison of two Scottish families with mutations in different genes causing autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia 2003, 44:613-617.
37. Miki D., Ochi H., Hayes C.N., Abe H., Yoshima T., Aikata H., Ikeda K., Kumada H., Toyota J., Morizono T., Tsunoda T., Kubo M., Nakamura Y., Kamatani N., Chayama K. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat. Genet. 2011, 43:797-800.
38. Phillips H.A., Scheffer I.E., Berkovic S.F., Hollway G.E., Sutherland G.R., Mulley J.C. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat. Genet. 1995, 10:117-118.
39. Phillips H.A., Marini C., Scheffer I.E., Sutherland G.R., Mulley J.C., Berkovic S.F. A de novo mutation in sporadic nocturnal frontal lobe epilepsy. Ann. Neurol. 2000, 48:264-267.
40. Prabowo A.S., Anink J.J., Lammens M., Nellist M., van den Ouweland A.M.W., Adle-Biassette H., Sarnat H.B., Flores-Sarnat L., Crino P.B., Aronica E. Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol. 2013, 23:45-59.
41. Rozycka A., Skorupska E., Kostyrko A., Trzeciak W.H. Evidence for S284L mutation of the CHRNA4 in a white family with autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia 2003, 44:1113-1117.
42. Scheffer I.E., Bhatia K.P., Lopes-Cendes I., Fish D.R., Marsden C.D., Andermann E., Andermann F., Desbiens R., Keene D., Cendes F., et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain 1995, 118:61-73.
43. Schutt J., Falley K., Richter D., Kreienkamp H.J., Kindler S. Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities. J. Biol. Chem. 2009, 284:25479-25487.
44. Seng T.J., Ichimura K., Liu L., Tingby O., Pearson D.M., Collins V.P. Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis. Genes Chromosomes Cancer 2005, 43:181-193.
45. Singh N.A., Charlier C., Stauffer D., DuPont B.R., Leach R.J., Melis R., Ronen G.M., Bjerre I., Quattlebaum T., Murphy J.V., McHarg M.L., Gagnon D., Rosales T.O., Peiffer A., Anderson V.E., Leppert M. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat. Genet. 1998, 18:25-29.
46. Steinlein O., Smigrodzki R., Lindstrom J., Anand R., Kohler M., Tocharoentanaphol C., Vogel F. Refinement of the localization of the gene for neuronal nicotinic acetylcholine-receptor alpha(4) subunit (Chrna4) to human-chromosome 20q13.2-Q13.3. Genomics 1994, 22:493-495.
47. Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., Scheffer I.E., Berkovic S.F. A missense mutation in the neuronal nicotinic acetylcholine-receptor alpha-4 subunit is associated with autosomal-dominant nocturnal frontal-lobe epilepsy. Nat. Genet. 1995, 11:201-203.
48. Steinlein O.K., Stoodt J., Mulley J., Berkovic S., Scheffer I.E., Brodtkorb E. Independent occurrence of the CHRNA4 Ser248Phe mutation in a Norwegian family with nocturnal frontal lobe epilepsy. Epilepsia 2000, 41:529-535.
49. Steinlein O.K., Hoda J.C., Bertrand S., Bertrand D. Mutations in familial nocturnal frontal lobe epilepsy might be associated with distinct neurological phenotypes. Seizure 2012, 21:118-123.
50. Tsai V., Parker W.E., Orlova K.A., Baybis M., Chi A.W., Berg B.D., Birnbaum J.F., Estevez J., Okochi K., Sarnat H.B., Flores-Sarnat L., Aronica E., Crino P.B. Fetal brain mTOR signaling activation in tuberous sclerosis complex. Cereb. Cortex 2012, 24:315-327. 10.1093/cercor/bhs310.
51. Vanderver A., Simons C., Schmidt J.L., Pearl P.L., Bloom M., Lavenstein B., Miller D., Grimmond S.M., Taft R.J. Identification of a novel de novo p.Phe932Ile KCNT1 mutation in a patient with leukoencephalopathy and severe epilepsy. Pediatr. Neurol. 2013, 50:112-114.
52. Vigevano F., Fusco L. Hypnic tonic postural seizures in healthy children provide evidence for a partial epileptic syndrome of frontal lobe origin. Epilepsia 1993, 34:110-119.
53. Zoncu R., Bar-Peled L., Efeyan A., Wang S.Y., Sancak Y., Sabatini D.M. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H+-ATPase. Science 2011, 334:678-683.